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(Springfield, IL, Charles C. Thomas, 1970, 65 pp.) will be much more useful in
writing the report.
The bookwill have its greatestvalue in counselingthebuddingscientist that things
never move as fast as hoped, that there are usually a few catastrophes during
research, that it is important to find a topic compatible with the laboratory in which
youwork, but not too similar towhat others in the lab are doing, and that sometimes
a topic turns out to have gone sour and would best be abandoned. But these sensible
bits ofinformation should be available from the thesis advisor or supervisor.
Much ofthis bookwould be worth a glance, even by an American neophyte; little




IMMUNOMODULATORS IN THE RHEUMATIC DISEASES. Edited by Daniel E. Furst and
Michael E. Weinblatt. New York, Marcel Dekker, Inc., 1990. 261 pp. $99.75.
Our limited understanding of the immune system and how it functions in health
and disease often makes the treatment of rheumatic diseases quite frustrating. Our
therapeutic armamentarium is small, frequently ineffective, and limited byuntoward
side effects. Recent advances in understanding how the immune system functions
and how it is able to go awry has led to the development of newer modalities of
therapyforthe autoimmune diseases. Thisbookoutlines some ofthestrategiesbeing
introduced and summarizes their effectiveness. I
The eightchapters, authoredbyknowledgeable expertsinthefield, arecomprehen-
sive reviews, each discussing a different modality. The first two chapters cover the
experience with methotrexate and immunosuppressive agents such as azothioprine,
alkylating agents, andcombination chemotherapy. Laterchaptersdealwithcyclospo-
rine, retinoids, and gamma interferon, which are experimental forms of therapy, as
well as the non-medicinal immunomodulators such as apheresis and total lymph
node irradiation. The final chapter is extremely well written and presents an
intriguingmodel ofthe pathogenesis ofrheumatoid arthritis and postulates as to the
direction newer therapeutic agentswill take.
Each chapter discusseswhat is known regardingthe chemistry, clinical pharmacol-
ogy, and toxicity ofeach drug. One ofthe strengths ofthis work is that each chapter
reviews the results of the clinical trials, has a summary statement, and includes an
extensive, up-to-date reference list. Ifthis volume has any failing, it is in the paucity
ofuseful diagrams, although the figures included were clear and accurately summa-
rized the data discussed. Those reading the book will gain insight into the rationale
and use of these agents and their role in the treatment of the rheumatic diseases,
especially rheumatoid arthritis.
For a multi-authored text, this is a well-organized and easily read work. I
recommend it to all physicians who deal with patients with rheumatic diseases, both
to assist in the management of these individuals and to gain further understanding
into the pathogenesis ofthese disorders.
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